Inactive Instrument

Calendar Qiagen Nasdaq

Equities

NL0012169213

Chart calendar Qiagen

172508b49a67c.LIDh71X9O3ElSARpaJyCeCtor0g2HE5F8cB6tHfwtME.VLiAjDqzdxMWOnEOMPS2Imk5439yVngqlJEj-hnB4oNr45uEFoV1A3MBVQ~a27ba51d86131fc22304eb5745b5a0b9

Upcoming events on Qiagen

15/05/2024 01:30 pm Berenberg MDx Day
22/05/2024 12:30 pm Deutsche Bank dbAccess European Champions Conference
17/06/2024 09:30 pm Capital Markets Day
26/06/2024 12:30 pm Stifel European Healthcare Summit
06/08/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
05/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Qiagen

Today 06:30 pm Q1 2024 Earnings Call
30/04/2024 01:35 am Q1 2024 Earnings Release
05/04/2024 American Association for Cancer Research Meeting
26/03/2024 06:30 pm BNP Exane Healthcare Conference
06/03/2024 12:40 am TD Cowen Health Care Conference
27/02/2024 01:30 pm UBS European Healthcare Conference
26/02/2024 01:30 pm Morgan Stanley European MedTech and Life Sciences Conference
07/02/2024 07:30 pm Q4 2023 Earnings Call
07/02/2024 02:35 am Q4 2023 Earnings Release
30/01/2024 Reverse Split: 24.25 of 25
30/01/2024 Capital return instalment
15/01/2024 08:30 pm German Corporate Conference
12/01/2024 01:30 pm ODDO BHF Forum
09/01/2024 07:30 pm Commerzbank and ODDO BHF German Investment Conference
09/01/2024 03:00 am JPMorgan Healthcare Conference
12/12/2023 Virtual DILS CEO Exane Conference
28/11/2023 11:00 pm Evercore ISI Healthcare Conference
22/11/2023 Kepler Cheuvreux Digital Diagnostics Day
31/10/2023 06:30 pm Q3 2023 Earnings Call
31/10/2023 01:35 am Q3 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
1 526
1 526
0.06%
1 870
1 858
0.68%
2 252
2 198
2.44%
2 142
2 139
0.12%
1 965
1 960
0.26%

2 011

EBITDA
Million USD
Released
Forecast
Spread
552
532
3.7%
748
723
3.4%
884
870
1.67%
790
791
-0.14%
659
675
-2.34%

831

EBIT
Million USD
Released
Forecast
Spread
422
412
2.5%
627
623
0.57%
755
714
5.73%
656
654
0.33%
529
524
0.88%

566

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-77,8
-77,9
0.13%
439
364
20.66%
626
564
11.04%
513
538
-4.72%
430
437
-1.7%

498

Net income
Million USD
Released
Forecast
Spread
-41,5
-29,5
-40.57%
359
294
22.31%
513
475
7.83%
423
424
-0.14%
341
344
-0.65%

380

EPS
USD
Released
Forecast
Spread
-0,19
-0,11
-62.85%
1,58
1,30
20.88%
2,28
2,17
4.8%
1,90
1,96
-2.99%
1,48
1,54
-3.96%

1,76

Announcement Date04/02/2009/02/2108/02/2210/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
582
533
9.18%
628
591
6.36%
516
500
3.15%
500
482
3.71%
498
486
2.55%
485
479
1.41%
495
493
0.38%
476
471
1.07%
509
504
1.01%
459
457
0.41%

501


506


541


489

EBITDA
Million USD
Released
Forecast
Spread
232
207
12.1%
266
240
11.11%
179
165
8.14%
176
158
11.2%
169
164
2.57%
158
163
-3.31%
168
194
-13.27%
158
149
5.95%
175
175
-0.02%
153
150
1.93%

175


179


200


168

EBIT
Million USD
Released
Forecast
Spread
199
171
16.22%
232
205
13.24%
146
133
10.33%
144
129
11.06%
135
128
5.61%
124
123
0.65%
136
134
1.4%
126
127
-0.37%
142
139
2.34%
118
117
0.49%

139


142


161


127

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread









95,7
94,5
1.29%






























Net income
Million USD
Released
Forecast
Spread
129
115
12.64%
155
138
12.44%
96,7
78,2
23.67%
82,4
78,1
5.44%
88,8
73,7
20.58%
85,0
75,1
13.24%
80,8
86,1
-6.2%
77,8
84,7
-8.14%
97,7
92,3
5.76%
80,7
76,3
5.79%

96,2


101


115


84,0

EPS
USD
Released
Forecast
Spread
0,58
0,51
12.18%
0,69
0,62
12.09%
0,43
0,36
21.29%
0,37
0,35
6.42%
0,40


0,38
0,33
14.04%
0,36
0,37
-2.98%
0,35
0,38
-8.76%
0,42
0,41
3.43%
0,36
0,34
6.88%

0,43


0,45


0,51


0,38

Announcement Date08/02/2227/04/2226/07/2207/11/2210/02/2303/05/2308/08/2330/10/2306/02/2429/04/24----